RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

$4.72
-0.16 (-3.28%)
As of Aug 8, 2:01 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +267.6% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $4.72
Current
$4.72
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
145.3%
Low target
Base Case
$17.35
+267.6%
Avg target
Bull Case
$20.59
+336.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$11.46
-58.8% from high
52-Week Low
$1.07
+341.1% from low
Target vs 52W High
$17.35
+51.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%